MarketsandMarkets
Leading Players - Philips Healthcare (Netherlands), GE Healthcare (U.K.), Siemens (Germany), McKesson Corporation (U.S.), Merge Healthcare (U.S.), and Agfa Healthcare (Belgium)
(PRWEB) June 04, 2014
The “Cardiovascular Information System/CVIS Market by Applications (Catheterization Lab, Vascular Lab, Echocardiography, Electrocardiography, Electrophysiology), Delivery Mode, End Users (Small, Medium and Large Hospitals) & Components - Forecasts to 2018” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the CVIS market along with the estimates and forecasts of the revenue and share analysis.
Browse 76 market data tables, 9 figures spread through 173 pages and in-depth TOC on “CVIS Market” http://www.marketsandmarkets.com/Market-Reports/cardiovascular-information-system-market-71504792.html.
Early buyers will receive 10% customization on this report.
The global CVIS market was valued at an estimated $160.0 Million in 2013 and is expected to reach $232.9 Million by 2018, growing at a CAGR of 7.8% from2013 and 2018.
Inquire before buying at http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=71504792.
The report segments this market based on application areas, provider entity capacity, components, delivery modes, and geography. Among various application areas, the echocardiography lab CVIS solution commanded the largest share in 2013 and is forecasted to be the fastest-growing segment in the CVIS market. Factors such as the need to curb the mortality rate due to cardiovascular diseases, necessity to streamline workflow across the cardiac care department, need to reduce healthcare cost, and the increasing requirement to overcome the issue with ‘data silos’ have increased the demand for CVIS.
Request for customization at http://www.marketsandmarkets.com/requestCustomization.asp?id=71504792.
Based on geography, the global CVIS market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the market in 2013. The large share of the North American region can be attributed to factors such as the growing need to control the rising healthcare costs and increasing government support in the form of funding for healthcare IT solutions, including CVIS solutions.
CVIS primarily provides imaging or analytical data handling software for the cardiology department. Across the globe, the adoption of CVIS solutions is increasing, due to factors such as the requirement to reduce the mortality rate due to cardiovascular diseases, necessity to streamline the cardiac care workflow in healthcare organizations, and overcome the issues with data silos in cardiac departments. Key market players are focusing on providing complete CVIS solutions at an affordable cost. With this view, companies are focusing on partnerships, collaborations, new product launches, and acquisitions, to increase their share in the market.
Growth in the CVIS market is likely to be centered at China, Singapore, India, Australia, and New Zealand. Healthcare organizations in the Asia-Pacific are actively moving towards digitization, to ensure patient safety and care, and streamline the entire workflow system in large healthcare enterprises. Government support for the adoption of healthcare IT solutions in this region is the key driver for the CVIS market. For instance, the Japanese government has taken various initiatives for growth of the healthcare IT market (subsequently developing the CVIS market). Initiatives such as ‘e-Japan policy’, ‘New IT reform strategy,’ and ‘i-Japan Strategy 2015’ have encouraged the growth of CVIS market in Japan.
The prominent players in the CVIS market include McKesson Corporation (U.S.), Philips Healthcare (Netherland), Siemens Healthcare (Germany), Lumedx (U.S.), Agfa Healthcare (Belgium), GE Healthcare (U.K.), Fujifilm (Japan), Merge Healthcare (U.S.), Digisonics (U.S.), and Cerner Corporation (U.S.).
Browse Related Reports:
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012 – 2017) - (Neurodegenerative, Cardiovascular, Cancer & Autoimmune, Skin and Infectious Diseases)
http://www.marketsandmarkets.com/Market-Reports/autologous-cell-therapy-market-837.html
Ablation Devices Market to 2016 - (Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Cardiac, Cancer and Gynecology) – Global Market Forecast and Trends Analysis by Technology, Devices & Applications
http://www.marketsandmarkets.com/Market-Reports/ablation-devices-market-791.html
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog at http://mnmblog.org/market-research/healthcare/healthcareit.